Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

A Multivariable Regression Model-based Nomogram for Estimating the Overall Survival of Patients Previously Treated With Nivolumab for Advanced Non-small-cell Lung Cancer

AKIHIRO TAMIYA, MOTOHIRO TAMIYA, HIROFUMI GO, TAKAKO INOUE, KEI KUNIMASA, KENJI NAKAHAMA, YOSHIHIKO TANIGUCHI, TAKAYUKI SHIROYAMA, SHUN-ICHI ISA, KAZUMI NISHINO, TORU KUMAGAI, HIDEKAZU SUZUKI, TOMONORI HIRASHIMA, SHINJI ATAGI, AYUMI SHINTANI and FUMIO IMAMURA
Anticancer Research August 2020, 40 (8) 4229-4236; DOI: https://doi.org/10.21873/anticanres.14424
AKIHIRO TAMIYA
1Internal Medicine, Kinki-Chuo Chest Medical Center, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MOTOHIRO TAMIYA
2Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: moto19781205{at}yahoo.co.jp
HIROFUMI GO
3Department of Medical Statistics, Osaka City University Graduate School of Medicine, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKAKO INOUE
2Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KEI KUNIMASA
2Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KENJI NAKAHAMA
4Respiratory Medicine, Ishikiriseiki Hospital, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YOSHIHIKO TANIGUCHI
1Internal Medicine, Kinki-Chuo Chest Medical Center, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKAYUKI SHIROYAMA
5Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHUN-ICHI ISA
6Clinical Research Center, Kinki-Chuo Chest Medical Center, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KAZUMI NISHINO
2Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TORU KUMAGAI
2Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIDEKAZU SUZUKI
7Thoracic Malignancy, Osaka Habikino Medical Center, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOMONORI HIRASHIMA
7Thoracic Malignancy, Osaka Habikino Medical Center, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHINJI ATAGI
6Clinical Research Center, Kinki-Chuo Chest Medical Center, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AYUMI SHINTANI
3Department of Medical Statistics, Osaka City University Graduate School of Medicine, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FUMIO IMAMURA
2Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 40 no. 8 4229-4236
DOI 
https://doi.org/10.21873/anticanres.14424
PMID 
32727749

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received May 8, 2020
  • Revision received June 21, 2020
  • Accepted June 25, 2020
  • Published online July 29, 2020.

Copyright & Usage 
Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

Author Information

  1. AKIHIRO TAMIYA1,
  2. MOTOHIRO TAMIYA2⇑,
  3. HIROFUMI GO3,
  4. TAKAKO INOUE2,
  5. KEI KUNIMASA2,
  6. KENJI NAKAHAMA4,
  7. YOSHIHIKO TANIGUCHI1,
  8. TAKAYUKI SHIROYAMA5,
  9. SHUN-ICHI ISA6,
  10. KAZUMI NISHINO2,
  11. TORU KUMAGAI2,
  12. HIDEKAZU SUZUKI7,
  13. TOMONORI HIRASHIMA7,
  14. SHINJI ATAGI6,
  15. AYUMI SHINTANI3 and
  16. FUMIO IMAMURA2
  1. 1Internal Medicine, Kinki-Chuo Chest Medical Center, Osaka, Japan
  2. 2Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan
  3. 3Department of Medical Statistics, Osaka City University Graduate School of Medicine, Osaka, Japan
  4. 4Respiratory Medicine, Ishikiriseiki Hospital, Osaka, Japan
  5. 5Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Osaka, Japan
  6. 6Clinical Research Center, Kinki-Chuo Chest Medical Center, Osaka, Japan
  7. 7Thoracic Malignancy, Osaka Habikino Medical Center, Osaka, Japan
  1. Correspondence to: Motohiro Tamiya, MD, Department of Thoracic Oncology, Osaka International Cancer Institute, 3-1-69 Otemae Tyuoku Osaka City, Japan. Tel.: +81 669451181, Fax: +81 669451900, e-mail: moto19781205{at}yahoo.co.jp Clinical trial number: UMIN000025908
View Full Text

Statistics from Altmetric.com

Cited By...

  • 5 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 40, Issue 8
August 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A Multivariable Regression Model-based Nomogram for Estimating the Overall Survival of Patients Previously Treated With Nivolumab for Advanced Non-small-cell Lung Cancer
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
7 + 11 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
A Multivariable Regression Model-based Nomogram for Estimating the Overall Survival of Patients Previously Treated With Nivolumab for Advanced Non-small-cell Lung Cancer
AKIHIRO TAMIYA, MOTOHIRO TAMIYA, HIROFUMI GO, TAKAKO INOUE, KEI KUNIMASA, KENJI NAKAHAMA, YOSHIHIKO TANIGUCHI, TAKAYUKI SHIROYAMA, SHUN-ICHI ISA, KAZUMI NISHINO, TORU KUMAGAI, HIDEKAZU SUZUKI, TOMONORI HIRASHIMA, SHINJI ATAGI, AYUMI SHINTANI, FUMIO IMAMURA
Anticancer Research Aug 2020, 40 (8) 4229-4236; DOI: 10.21873/anticanres.14424

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
A Multivariable Regression Model-based Nomogram for Estimating the Overall Survival of Patients Previously Treated With Nivolumab for Advanced Non-small-cell Lung Cancer
AKIHIRO TAMIYA, MOTOHIRO TAMIYA, HIROFUMI GO, TAKAKO INOUE, KEI KUNIMASA, KENJI NAKAHAMA, YOSHIHIKO TANIGUCHI, TAKAYUKI SHIROYAMA, SHUN-ICHI ISA, KAZUMI NISHINO, TORU KUMAGAI, HIDEKAZU SUZUKI, TOMONORI HIRASHIMA, SHINJI ATAGI, AYUMI SHINTANI, FUMIO IMAMURA
Anticancer Research Aug 2020, 40 (8) 4229-4236; DOI: 10.21873/anticanres.14424
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Discontinuation of Immune Checkpoint Inhibitor and Survival in Patients With Non-small-cell Lung Cancer Without a Driver Gene Mutation
  • Google Scholar

More in this TOC Section

  • Laparotomy After Total Pelvic Exenteration: Current Status and Techniques for Ileal Conduit Preservation
  • Pregabalin for Opioid-resistant Neuropathic Pain in Bone Metastases
  • Life-threatening Pneumonitis Induced by Osimertinib Monotherapy as a First-line Treatment for Epidermal Growth Factor Receptor Mutation-positive Non-small-cell Lung Cancer: A Retrospective Case-series Study
Show more Clinical Studies

Keywords

  • non-small-cell lung cancer
  • nivolumab
  • nomogram
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire